Donepezil Effects on Language in Children With Down Syndrome: Results of the First 22-Week Pilot Clinical Trial

Podobné jednotky

• Donepezil for the Treatment of Language Deficits in Adults With Down Syndrome: A Preliminary 24-Week Open Trial
  Autor: Heller, James H., a další
  Vydáno: (2003)
• Safety and Efficacy of Rivastigmine in Adolescents with Down Syndrome: A Preliminary 20-Week, Open-Label Study
  Autor: Heller, James H., a další
  Vydáno: (2006)
• Safety and Efficacy of Rivastigmine in Adolescents with Down Syndrome: Long-Term Follow-Up
  Autor: Heller, James H., a další
  Vydáno: (2010)
• Assessment of Cognitive Scales to Examine Memory, Executive Function and Language in Individuals with Down Syndrome: Implications of a 6-month Observational Study
  Autor: Liogier d'Ardhuy, Xavier, a další
  Vydáno: (2015)
• Donepezil for dementia in people with Down syndrome
  Autor: Mohan, Monica, a další
  Vydáno: (2009)